During the last Apple conference call, Steve Jobs crowed about Apple’s (s aapl) growing enterprise presence. Today, a new report illustrates just how well iOS in particular is doing in business; 4,000 new iPads and iPhones are ready to be put to use at a major pharmaceutical company, the report says.
Issued by OpenTrust, a software security provider that was tasked with creating a secure network for the devices, the report doesn’t reveal which pharmaceutical company is bringing in the Apple hardware. It does note that the new customer has a large international presence, spanning more than 100 countries, and claiming more than 100,000 employees worldwide. That’s right around Pfizer (s pfe) and GlaxoSmithKline (s gsk) territory, in case you were wondering.
Apple touted its presence within top companies last Wednesday, when Jobs noted during the conference call that the iPhone is being piloted or deployed by 80 percent of Fortune 100 companies, while the iPad has presence at 66 percent.
The OpenTrust announcement reveals some interesting usage information about how iOS devices are operating in corporate IT, too. The company’s focus seems to have been on enabling secure remote access for distributed employees dialing in from abroad. If remote workforces are pushing the enterprise drive toward iOS adoption, then that’s promising news for Apple, as the number of employees who commute virtually is on the rise.
Related content from GigaOM Pro (sub req’d):